Skip Nav Destination
About the Journal
Cancer Discovery publishes high-impact articles featuring major advances in research and clinical trials. Topics span the spectrum of cancer research and medicine from the laboratory to the clinic to epidemiologic studies. The journal also publishes News and Research Watch sections.Read More About the Journal
Impact Factor
28.2
Featured Articles
AACR Cancer Centers Alliance: Fostering Collaboration and Innovation to Advance Lifesaving Scientific Discoveries for Patients
Carlos L. Arteaga; John L. Cleveland; Margaret Foti; Ruben A. Mesa; Louis M. Weiner; Cheryl L. Willman; David A. Tuveson
GABA regulates electrical activity and tumor initiation in melanoma
Mohita Tagore, et al.
Noted This Week
President Joe Biden’s Cancer Cabinet met to present and discuss new Cancer Moonshot initiatives aimed at halving the death rate from cancer by 2047. The announcements included word of $240 million investment from the Advanced Research Projects Agency for Health (ARPA-H) to accelerate innovative projects to prevent, detect, treat, and survive cancer; a program to pioneer technologies to make data more readily accessible; a nationwide network to bring cancer clinical trials to underserved communities; and an expansion of efforts to prevent smoking and increase smoking cessation.
Trending - Altmetric
Read the article titled, Structural basis of PML/RARA oncoprotein targeting by arsenic unravels a cysteine rheostat controlling PML body assembly and function
Last mentioned on Thursday September 21 2023
Read the article titled, Achieving the Goals of the Cancer Moonshot Requires Progress against All Cancers
Last mentioned on Wednesday September 20 2023
Read the article titled, Opportunities for Achieving the Cancer Moonshot Goal of a 50% Reduction in Cancer Mortality by 2047
Last mentioned on Wednesday September 20 2023
Read the article titled, Early-Stage Breast Cancer Detection in Breast Milk
Last mentioned on Thursday September 21 2023
Read the article titled, STX-478, a Mutant-Selective, Allosteric PI3Ka Inhibitor Spares Metabolic Dysfunction and Improves Therapeutic Response in PI3Ka-Mutant Xenografts
Last mentioned on Wednesday September 20 2023
The Twitter live feed is not currently active.
Keep up to date with Cancer Discovery
Advertisement